Ligand Pharmaceuticals
LGND
#4143
Rank
โ‚ฌ2.08 B
Marketcap
110,60ย โ‚ฌ
Share price
0.61%
Change (1 day)
71.87%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ0.10 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are โ‚ฌ0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ78.06 M-49.3%
2022-12-31โ‚ฌ0.15 B-63.4%
2021-12-31โ‚ฌ0.42 B-20.73%
2020-12-31โ‚ฌ0.53 B-18.3%
2019-12-31โ‚ฌ0.64 B6.18%
2018-12-31โ‚ฌ0.61 B190.86%
2017-12-31โ‚ฌ0.21 B-4.11%
2016-12-31โ‚ฌ0.21 B6.06%
2015-12-31โ‚ฌ0.20 B7.68%
2014-12-31โ‚ฌ0.19 B381.45%
2013-12-31โ‚ฌ39.89 M-32.14%
2012-12-31โ‚ฌ58.79 M-32.07%
2011-12-31โ‚ฌ86.54 M43.17%
2010-12-31โ‚ฌ60.45 M-37.27%
2009-12-31โ‚ฌ96.36 M-25.9%
2008-12-31โ‚ฌ0.13 B31.72%
2007-12-31โ‚ฌ98.73 M-56.38%
2006-12-31โ‚ฌ0.22 B-36.91%
2005-12-31โ‚ฌ0.35 B19.36%
2004-12-31โ‚ฌ0.30 B7.64%
2003-12-31โ‚ฌ0.27 B44.94%
2002-12-31โ‚ฌ0.19 B-2.96%
2001-12-31โ‚ฌ0.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ80.42 B 73,219.96%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ78.02 M-28.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ57.58 B 52,398.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ70.40 B 64,086.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ122.44 B 111,537.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ59.12 B 53,807.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ73.77 B 67,163.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ18.07 B 16,378.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ104.32 B 95,010.30%๐Ÿ‡บ๐Ÿ‡ธ USA